FDA Approvals: Nascobal Nasal Spray, PTC 124, Tocosol Paclitaxel

The FDA has approved a nasal spray formulation of cyanocobalamin (Nascobal); a new indication for orphan drug PTC 124; and orphan drug status for a new formulation of paclitaxel (Tocosol paclitaxel).Yael Waknine

Continue to FDA Approvals: Nascobal Nasal Spray, PTC 124, Tocosol Paclitaxel on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz